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Abstract: Imbalanced maternal micronutrient status, poor placentation, and oxidative stress are
associated with greater risk of pregnancy complications, which impact mother and offspring health.
As selenium, iodine, and copper are essential micronutrients with key roles in antioxidant systems,
this study investigated their potential protective effects on placenta against oxidative stress. First
trimester human placenta explants were treated with different concentrations of selenium (sodium
selenite), iodine (potassium iodide), their combination or copper (copper (II) sulfate). The concentra-
tions represented deficient, physiological, or super physiological levels. Oxidative stress was induced
by menadione or antimycin. Placenta explants were collected, fixed, processed, and embedded
for laser ablation inductively coupled plasma-mass spectrometry (LA ICP-MS) element imaging
or immunohistochemical labelling. LA ICP-MS showed that placenta could uptake selenium and
copper from the media. Sodium selenite and potassium iodide reduced DNA damage and apoptosis
(p < 0.05). Following oxidative stress induction, a higher concentration of sodium selenite (1.6 µM)
was needed to reduce DNA damage and apoptosis while both concentrations of potassium iodide
(0.5 and 1 µM) were protective (p < 0.05). A high concentration of copper (40 µM) increased apoptosis
and DNA damage but this effect was no longer significant after induction of oxidative stress. Mi-
cronutrients supplementation can increase their content within the placenta and an optimal maternal
micronutrient level is essential for placenta health.
Keywords: apoptosis; copper; DNA damage; iodine; micronutrient supplement; oxidative stress;
placenta; pregnancy; selenium
1. Introduction
Maternal nutrition during early pregnancy is critical for fetal growth and development
and can impact the future health of the offspring later in life [1,2]. A deficiency or excess
in micronutrients such as selenium, copper, and iodine measured in maternal plasma,
serum, or urine are associated with a greater risk of pregnancy complications such as
preeclampsia, gestational diabetes mellitus, spontaneous preterm birth, and small-for-
gestational age [3–7]. The detrimental effects of pregnancy complications are not limited to
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the pregnancy as their long-term consequences can impact the health of both mother and
child later in life [8–10]. Thus, it is of paramount importance to determine the nutritional
risk factors related to pregnancy complications and devise potential preventive strategies.
The placenta is the key mediator of maternal nutrient supply to the fetus. Poor placen-
tal development, including incomplete remodelling of arteries during early pregnancy, has
been associated with pregnancy complications like preeclampsia [11]. Partial remodelling
of the maternal arteries causes hypoxia followed by reoxygenation that result in oxidative
stress [12]. Oxidative stress is frequently associated with a range of pregnancy complica-
tions [13,14]. Oxidative stress is caused by accumulated reactive oxygen molecules and
insufficient antioxidant activity [15,16], and results in damage of molecules such as lipids,
proteins and DNA; thus, tissue decay [16]. In addition, oxidative stress can increase apopto-
sis and this leads to high shedding of syncytial fragments into maternal blood resulting in
a systemic inflammatory response, which is associated with pregnancy complications [17].
Micronutrients and oxidative stress are related through the antioxidant system [18,19].
For instance, glutathione peroxidase (GPx) and superoxide dismutase 1 (SOD1) are two
antioxidant enzymes that require micronutrients for proper function [18,19]. GPx needs
selenium and SOD1 requires copper or zinc to scavenge radicals and prevent oxidative
stress [18,19]. Studying micronutrient status in relation to placental development and
oxidative stress may help elucidate the mechanisms involved in pregnancy complications.
Although population studies have shown that selenium supplementation is associated
with a lower incidence of preeclampsia and premature rupture of membranes [20–22], the
impact of micronutrients on placental development is still unknown. In addition, there
is no information on potential interactions between selenium and other micronutrients.
Iodine is an essential micronutrient and its deficiency during pregnancy puts both mother
and offspring at a greater risk of pregnancy complications such as gestational hypertension,
intrauterine growth restriction and preterm birth [7,23–27]. We recently showed that
selenium and iodine deficiency are associated with lower cell proliferation and higher cell
death and lipid peroxidation in HTR8/SVneo trophoblast cells (Habibi et al., 2020). In
addition, individual or combined supplementation with selenium and iodine protected
trophoblast cells against oxidative stress by enhancing cell viability and proliferation and
reducing lipid peroxidation [28].
Copper is another essential component in a variety of metalloenzymes [29] including
the antioxidant SOD1 enzyme [18]. High copper levels in maternal serum have been
associated with a greater level of inflammation [3]. Investigating how copper may impact
the placenta will help to understand its role and impact on pregnancy outcome. This study
investigated how selenium, iodine, and copper may affect oxidative stress response in
first trimester human placenta by assessing their effect on proliferation, apoptosis, and
DNA damage.
2. Materials and Methods
2.1. Placenta Explant Tissue Culture
First trimester (7–12 weeks’ gestation; determined from last menstrual period) human
placenta tissue samples (n = 15) were collected with informed consent from women who
underwent elective pregnancy terminations at the Pregnancy Advisory Centre, Woodville,
South Australia. The age and BMI (mean ± SD) of participants were 28.83 ± 7.18 years
and 25.36 ± 3.38 kg/m2, respectively. Samples were collected from participants that were
Caucasian and terminations were not due to medical issues.
Within an hour of termination, 10–15 mg of placenta tissue sections (3–4 pieces)
were cultured on a pre-prepared gel base in each well of a 48-well plate. The gel base
was Growth Factor Reduced Matrigel® (protein concentration: 3 mg/mL; Corning®) and
1X DMEM GlutaMAX™ media (Gibco® Life Technologies™) containing 10% v/v FBS
(Sigma-Aldrich®) and 1% v/v Antibiotic–Antimycotic (Life Technologies™) at pH 7.0.
Culture conditions were maintained at 37 ◦C, 5% CO2, and 1% O2 for the duration of the
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experiments. Placenta explants were first cultured for 48 h to enable regeneration of the
syncytial layer.
Explants were supplemented with sodium selenite (Sigma Aldrich®) (0, 0.8, or 1.6 µM),
potassium iodide (Sigma Aldrich®) (0, 0.5, or 1 µM), copper (II) sulfate (Sigma Aldrich®)
(0, 20, or 40 µM), a combination of sodium selenite and potassium iodide (0.8 µM sodium
selenite and 0.5 µM potassium iodide), or sterile Milli-Q water for 72 h with supplemen-
tation replenished every 24 h. These concentrations represent the low, physiological and
supraphysiological level as measured in maternal blood during pregnancy [3,30].
Explants were then treated with 120 µM menadione, 480 µM antimycin or 0.1%
ethanol (vehicle for menadione and antimycin) for 24 h. Explants were harvested and
fixed in 10% neutral buffered formalin for 2 h at room temperature, then washed 3 times
with 1X phosphate buffered saline (PBS) for 24 h at 4 ◦C and stored in 70% ethanol at
4 ◦C until processing. Explants were processed and embedded in paraffin blocks for
downstream assessments.
2.2. Micronutrient Uptake
To evaluate if placenta tissue explants take up selenium and copper, three first trimester
placentas from 7 to 12 weeks’ gestation were cultured for 5 days including 48 h syncytial
layer regeneration, and 72 h of supplementation with (0, 0.8, and 1.6 µM) sodium selenite
or (0, 20, or 40 µM) copper (II) sulfate as above. Explants were then harvested, fixed, and
paraffin embedded. Tissue sections of 10 µm were placed on microscope slides. Sections
were heated for 2 h at 60 ◦C, then dewaxed with 100% xylene and 100% ethanol and
washed with PBS two times and finally air dried overnight. Standards were made by
dissolving 10% gelatine (Sigma Aldrich®) in elements solutions of selenium and copper
with 0, 1, 10, and 100 mM concentrations. Gelatine blocks were mounted in Tissue-Tek
OCT Compound medium. Gelatine blocks were cut in 10 µm sections to match placenta
explant sections using a cryomicrotome (Leica CM3050s Cryostat). After placing gelatine
sections on the microscope slides, they were kept at−20 ◦C. Gelatine sections were air dried
overnight before laser ablation (LA) inductively coupled plasma-mass spectrometry (ICP-
MS) analyses (Adelaide Microscopy, University of Adelaide), using an attached Resolution
193 nm excimer laser ablation system coupled to an Agilent 7900x ICP-MS. Samples were
ablated with a series of parallel lines with the following conditions: 23 µm spots size,
23 µm/s speed, 10 Hz repetition rate, and a fluence of ~1 J/cm2. Intensity of micronutrients
were recorded as counts per second for the following isotopes: 13C, 23Na, 24Mg, 29Mg,
31P, 39K, 43Ca, 57Fe, 65Cu, 66Zn, and 77Se. Only the elements of most interest (Se and
Cu) are discussed in detail. Data was processed using the iolite data processing software,
and concentrations were calculated and visualised relative to the gelatine standards to
form a 2D map of micronutrient concentration over a chosen surface of each placenta
explant sample.
2.3. Assessment of Proliferation, Apoptosis and DNA Damage
To assess the effect of supplementation on placental proliferation, apoptosis and DNA
damage, explants from first trimester placentas (n = 12) of 7–12 weeks’ gestation were
cultured as mentioned above. Tissue sections of 5 µm were placed on microscope slides for
immunohistochemical labelling for assessment of proliferation (Ki67; Abcam®; ab16667),
apoptosis (cleaved caspase-3; Cell Signalling Technology®; CST.9661L) or DNA damage
(8-hydroxy-2’-deoxyguanosine; Abcam®; ab48508) (Table 1). A Hamamatsu NanoZoomer
Digital Pathology slide scanner was used to scan the stained sections. Eight areas per
explant tissue, randomly chosen using NDP.view2 software, were used for quantification
and statistical analyses. Positively stained cells per mm2/area were counted.
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Table 1. Antibodies used for immunohistochemical labelling.
Antibody Dilution TargetSpecies CAT # Company Diluent Antigen Retrieval
Ki67 1/100 Rabbit ab16667 Abcam® 5% Goat serum
Citrate buffer (10 mM Citric
acid; pH 6.0; 10 min boiling
in microwave, Sixth Sense,
Whirlpool, VIC, Australia)
cleaved
caspase-3 1/100 Rabbit CST.9661L
Cell Signalling
Technology® 5% Goat serum
Citrate buffer (10 mM Citric
acid; pH 6.0; 10 min boiling
in microwave)
8-hydroxy-2’-
deoxyguanosine 1/200 Mouse ab48508 Abcam
® 5% Goat serum
Citrate buffer (10 mM Citric
acid; pH 6.0; 10 min boiling
in microwave)
# refers to number.
2.4. Statistical Analyses
Proliferation, apoptosis, and DNA damage are expressed as a fold change (FC) relative
to the control of each experiment ± standard error. To examine differences between
micronutrient-treated and non-treated groups, generalised estimating equations (GEE)
were used with log2-transformed positive stain per area to estimate fold change compared
to controls. Independence correlation structure was assumed for the GEE to account
for measurements from multiple regions per explant. Pre-specified post-hoc contrasts
comparing individual sodium selenite and potassium iodide treatments with combination
of sodium selenite and potassium iodide were performed with Bonferroni adjustment for
multiple comparisons. P-values of less than 0.05 were considered significant. All analyses
were performed using R version 3.5.3 or later.
3. Results
3.1. Confirmation of Micronutrient Uptake within the Treated First Trimester Placenta Explants
Qualitative assessment of micronutrient distributions with laser ablation inductively
coupled plasma-mass spectrometry (LA-ICP-MS) element imaging showed that supple-
mentation with selenium and copper increased the content of these micronutrients in the
placenta explants confirming the micronutrient uptake by explants from the media supple-
mented with selenium and copper (Figure 1; Supplementary Figures S1 and S2). In all three
placentas, highest uptake of selenium was found in tissues treated with supraphysiological
concentration of sodium selenite (1.6 µM) indicated by more red and yellow pixels in the
LA-ICP-MS images (Figure 1d–f, Supplementary Figure S1d–f,j–l). In two placentas, it was
apparent that with increasing selenium concentration, there was an increased uptake of
selenium on the 2D map (Figure 1d–f and Supplementary Figure S1j–l). Assessment of
tissues treated with copper (II) sulfate showed that control tissues had the lowest level
of copper visualised by dark and light blue pixels. All tissues supplemented with phys-
iological concentration (20 µM) copper (II) sulfate and two tissues supplemented with
supraphysiological concentration of copper (II) sulfate (40 µM) (Figure 1j–l; Supplementary
Figure S2d–f,j–l) had a higher content of copper compared to the control. This method was
not able to assess iodine uptake.





Figure 1. Selenium and copper uptake in first trimester human placental explants. Placenta ex-
plants (7–12 weeks of gestation) were supplemented with sodium selenite (a and d: sterile MilliQ 
water, b and e: 0.8 µM or c and f: 1.6 µM) or copper (II) sulfate (g and j: sterile MilliQ water, h and 
k: 20 µM or i and l: 40 µM) for 72 hours (n = 3). Tissue sections (10 µm) were placed on microscope 
slides. Standards were made by dissolving 10% gelatine in 0, 1, 10, and 100 mM solutions of sele-
nium and copper. Laser ablation inductively coupled plasma-mass spectrometry (LA-ICP-MS) 
analyses on the standard gelatine and placental explant sections were analysed using a Resolution 
193 nm excimer laser ablation system coupled to an Agilent 7900x ICP-MS. Samples were ablated 
with a series of parallel lines: 23 µm spots size, 23 µm/s speed, 10 Hz repetition rate and a fluence 
of ~1 J/cm2. Intensity of micronutrients were recorded as counts per second for each isotope. Data 
was processed using the iolite data processing software, and element intensity calculated relative 
to the gelatine standards to form a 2D map of micronutrient distribution over a chosen surface of 
each placental explant sample. 
3.2. Apoptosis and DNA damage induction by menadione and antimycin 
A dose response experiment (n = 3) was performed to find the optimal concentration 
of menadione and antimycin for inducing oxidative stress in first trimester human pla-
centa tissue. The following concentrations of menadione (0, 60, 120, and 240 µM) and an-
timycin (0, 240, 480, and 960 µM) were tested. Immunohistochemical analysis for DNA 
damage using 8-hydroxy-2’-deoxyguanosine was used to select the optimal concentration 
Figure 1. Selenium and copper uptake in first trimester human placental explants. Placenta explants (7–12 weeks of
gestation) were supplemented with sodium selenite (a and d: sterile MilliQ water, b and e: 0.8 µM or c and f: 1.6 µM) or
copper (II) sulfate (g and j: sterile MilliQ water, h and k: 20 µM or i and l: 40 µM) for 72 h (n = 3). Tissue sections (10 µm)
were placed on microscope slides. Standards were made by dissolving 10% gelatine in 0, 1, 10, and 100 mM solutions of
selenium and copper. Laser ablation inductively coupled plasma-mass spectrometry (LA-ICP-MS) analyses on the standard
gelatine and placental explant sections were analysed using a Resolutio 193 nm excimer laser ablation system c upled
to a Agilent 7900x ICP-MS. Samples were ablated with a series of parallel lines: 23 µm pots size, 23 µm/s speed, 10 Hz
repetition rate and a fluence of ~1 J/cm2. Intensity of micronutrients were recorded as counts per second for each isotope.
Data was processed using the iolite data processing software, and element intensity calculated relative to the gelatine
standards to form a 2D map of micronutrient distribution over a chosen surface of each placental explant sample.
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3.2. Apoptosis and DNA Damage Induction by Menadione and Antimycin
A dose response experiment (n = 3) was performed to find the optimal concentration
of menadione and antimycin for inducing oxidative stress in first trimester human placenta
tissue. The following concentrations of menadione (0, 60, 120, and 240 µM) and antimycin
(0, 240, 480, and 960 µM) were tested. Immunohistochemical analysis for DNA damage
using 8-hydroxy-2’-deoxyguanosine was used to select the optimal concentration that in-
duced sufficient DNA damage compared to vehicle control in the absence of micronutrient
supplementation. The concentrations selected were 120 µM for menadione and 480 µM
for antimycin.
In the 12 first trimester placenta explants used in this study, immunohistochem-
istry analyses showed that compared to vehicle control (0.1 % ethanol) 120 µM mena-
dione and 480 µM antimycin, in the absence of micronutrient supplementation, signif-
icantly increased the number of apoptotic cells and DNA damage (p < 0.05) (Figure 2
and Supplementary Figure S3). This confirmed that oxidative stress was induced in the
cultured first trimester placenta explants and that this system could be used to assess
whether micronutrient supplementation protects against induced oxidative stress.
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media with 10% v/v FBS and 1% v/v Antibiotic-Antimycotic and then treated with 120 µM mena-
dione, 480 µM antimycin or 0.1% ethanol (vehicle control) for 24 hours. Immunohistochemical 
labelling for (a) apoptosis (cleaved caspase-3) or (b) DNA damage (8-hydroxy-2’-deoxyguanosine) 
was performed. Eight randomly selected regions per explant were used for quantification and 
statistical analyses. Data are presented as a fold change (FC) relative to control ± standard error. 
Statistical significance was assessed using Generalised Estimating Equations with independence 
correlation structure with log 2-transformed positive stain per area to estimate fold change com-
pared to controls followed by pre-specified post-hoc Bonferroni adjusted multiple comparisons. * 
Indicates statistically different (p < 0.05) from control. 
3.3. Effect of selenium, iodine and copper supplementation on proliferation 
Ki67 positivity was used to assess whether any of the micronutrients altered prolif-
eration within the treated placenta explant tissues in the absence of oxidative stress. There 
were no changes in proliferation except for treatment with 1.6 µM sodium selenite which 
increased cell proliferation after 72 hours of supplementation (0.58, 95% CI: 0.25, 0.90) 
(Figure 3a). When oxidative stress was induced, with menadione or antimycin, there were 
no changes in proliferation except for supraphysiological concentration of selenium which 
again showed an increase in the number of Ki67 positive cells per mm2 after treatment 
with menadione (0.63, 95% CI: 0.31, 0.95) (Figure 3b), or antimycin (0.39, 95% CI: 0.11, 0.67) 
(Figure. 3c) (p < 0.05). 
Figure 2. f ect of menadione and antimycin on apoptosis and DNA damage in first trimester human placental explants.
Explants from 7–12 weeks of gestation (n = 12) were cultured for 5 days in media with 10% v/v FBS and 1% v/v Antibiotic-
Antimycotic and then treated with 120 µM menadione, 480 µM antimycin or 0.1% ethanol (vehicle control) for 24 h.
Immunohistochemical labelling for (a) apoptosis (cleaved caspase-3) or (b) DNA damage (8-hydroxy-2’-deoxyguanosine)
was performed. Eight randomly selected regions per explant were used for quantification and statistical analyses. Data are
prese ted as a fold change (FC) relative to control ± standard e ror. Statistical significance was assessed using Generalised
Estimating Equations with independence correlation structure with log 2-transformed positive stain per area to estimate
fold change compared to controls followed by pre-specified post-hoc Bonferroni adjusted multiple comparisons. * Indicates
statistically different (p < 0.05) from control.
3.3. Effect of Sele ium, Iodine and Copp r Supplementation on Proliferation
Ki67 ositivity was used to assess whethe any of the micronutrients altered prolifera-
tion within the treated placenta explant tissues in the absence of oxidative stress. There
were no changes in proliferation except for treatment with 1.6 µM sodium selenite which
increased cell proliferation after 72 h of supplementation (0.58, 95% CI: 0.25, 0.90) (Figure
3a). When oxidative stress was induced, with menadione or antimycin, there were no
changes in proliferation except for supraphysiological concentration of selenium which
again showed an increase in the number of Ki67 positive cells per mm2 after treatment
with menadione (0.63, 95% CI: 0.31, 0.95) (Figure 3b), or antimycin (0.39, 95% CI: 0.11, 0.67)
(Figure 3c) (p < 0.05).
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dione or (c) 480 µM antimycin for 24 hours to induce oxidative stress and then assessed for prolif-
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Figure 3. Effect of selenium, iodine, and copper supplementation on proliferation in first trimester
placental explants. Placenta explants from 7 to 12 weeks of gestation (n = 12) were cultured for 48 h
for syncytial regeneration f llowed by supplementation with sodium selenite (0, 0.8, or 1.6 µM),
potassiu iodide (0, 0.5, or 1 µM), combination of sodium selenite and potassium iodide (0.8 µM
sodium selenite and 0.5 µM potassium iodide), or copper (II) sulfate (0, 20, or 40 µM) for 72 h with
supplementation replenished every 24 h. (a) Placental explants were harvested following 72 h of
supplementation a d proliferation assesse by immunolabelli g for Ki67. In addition, after 72 h
supplementation, placental explants were treated with (b) 120 µM menadione or (c) 480 µM antimycin
for 24 h to induce oxidative stress and then assessed for proliferation. Eight randomly selected regions
per explant were used for quantification and statistical analyses. Data presented as a fold change
(FC) relative to control ± standard error. Statistical significance was assessed using Generalised
Estimating Equations with independence correlation structure with log 2-transformed positive stain
per area to estimate fold change compared to controls followed by pre-specified post-hoc Bonferroni
adjusted comparisons. * Indicates statistically different (p < 0.05) from vehicle control (C).
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3.4. Effect of Selenium, Iodine, and Copper Supplementation on Apoptosis
In the absence of oxidative stress, both 0.8 and 1.6 µM sodium selenite reduced
apoptosis (−0.25, 95% CI: −0.44, −0.053 and −0.54, 95% CI: −0.83, −0.25, respectively)
compared to control (sterile MilliQ water) (Figure 4a). Potassium iodide (0.5, 1 µM)
significantly reduced apoptosis (−0.73, 95% CI: −1.06, −0.41 and −0.82, 95% CI: −1.18,
−0.46, respectively) (Figure 4a). The combination of 0.8 µM sodium selenite and 0.5 µM
potassium iodide also reduced apoptosis compared to the vehicle control (−0.68, 95% CI:
−0.96, −0.4) (p < 0.05) (Figure 4a). In addition, the effect of the combination of sodium
selenite and potassium iodide in apoptosis reduction was significantly more than individual
supplementation with 0.8 µM sodium selenite (p < 0.05) but not 0.5 µM potassium iodide.
Treatment with supraphysiological concentration of copper (II) sulfate (40 µM) significantly
increased apoptosis (0.35, 95% CI: 0.11, 0.60) compared to control (Figure 4a).




Figure 4. Effect of selenium, iodine, and copper supplementation on apoptosis in first trimester placental explants. Pla-
centa explants from 7 to 12 weeks of gestation (n = 12) were cultured for 48 hours for syncytial regeneration followed by 
supplementation with sodium selenite (0, 0.8, or 1.6 µM), potassium iodide (0, 0.5, or 1 µM), combination of sodium sele-
nite and potassium iodide (0.8 µM sodium selenite and 0.5 µM potassium iodide), or copper (II) sulfate (0, 20, or 40 µM) 
for 72 hours with supplementation replenished every 24 hours. (a) Placental explants were harvested at the end of 72 hours 
supplementation and apoptosis assessed by immunolabelling for cleaved caspase-3. In addition, after 72 hours supple-
mentation, placental explants were treated with (b) 120 µM menadione or (c) 480 µM antimycin for 24 hours to induce 
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placental explants. Placenta explants from 7 to 12 weeks of gestation (n = 12) were cultured for 48 h
for syncytial regeneration followed by supplementation with sodium selenite (0, 0.8, or 1.6 µM),
potassium iodide (0, 0.5, or 1 µM), combination of sodium selenite and potassium iodide (0.8 µM
sodium selenite and 0.5 µM potassium iodide), or copper (II) sulfate (0, 20, or 40 µM) for 72 h with
supplementation replenished every 24 h. (a) Placental explants were harvested at the end of 72 h
supplementation and apoptosis assessed by immunolabelling for cleaved caspase-3. In addition,
after 72 h supplementation, placental explants were treated with (b) 120 µM menadione or (c) 480 µM
antimycin for 24 h to induce oxidative stress and then assessed for apoptosis. Eight randomly selected
regions per explant were used for quantification and statistical analyses. Data presented as a fold
change (FC) relative to control ± standard error. Statistical significance was assessed using Generalised
Estimating Equations with independence correlation structure with log 2-transformed positive stain
per area to estimate fold change compared to controls followed by pre-specified post-hoc Bonferroni
adjusted comparisons. * Indicates statistically different (p < 0.05) from control.
Assessment of apoptosis following induction of oxidative stress by menadione showed
that 1.6 µM sodium selenite (−1.04, 95%CI: −1.25, −0.84), both 0.5 µM (−1.34, 95%CI:
−1.64, −1.04) and 1 µM potassium iodide (−1.28, 95%CI: −1.65, −0.91), and the combina-
tion of 0.8 µM sodium selenite and 0.5 µM potassium iodide (−1.1, 95%CI: −1.32, −0.84)
were associated with a significant reduction in apoptosis (p < 0.05) when compared to
the menadione alone control (Figure 4b). Combination of sodium selenite and potassium
iodide reduced apoptosis more than 0.8 µM sodium selenite (p < 0.05) but not more than
potassium iodide (0.5 µM) alone (Figure 4b). Copper (II) sulfate did not significantly
impact apoptosis (p > 0.05) (Figure 4b). Similar results were seen when oxidative stress was
induced using antimycin (Figure 4c), that is, reduction in apoptosis with the higher dose of
sodium selenite (1.6 µM), both potassium iodide concentrations (0.5 and 1 µM) and sodium
selenite and potassium iodide combination but no changes in apoptosis with copper (II)
sulfate compared to the antimycin alone control (Figure 4c).
3.5. Effect of Selenium, Iodine and Copper Supplementation on DNA Damage
Both concentrations of sodium selenite 0.8 µM (−0.4, 95% CI: −0.6, −0.16) and 1.6
µM (−0.65, 95% CI: −1.27, −0.02), potassium iodide 0.5 µM (−0.42, 95% CI: −0.83, −0.02),
1 µM (−0.43, 95% CI: −0.85, 0.01), and the combination of 0.8 µM sodium selenite and
0.5 µM potassium iodide (−0.73, 95% CI: −1.18, −0.29) reduced DNA damage compared
to control (sterile MilliQ water) following 72 h of treatment (p < 0.05) (Figure 5a). However,
the effect of the combination of sodium selenite and potassium iodide was not significantly
different from individual supplementation with sodium selenite or potassium iodide
(p > 0.05) (Figure 5a). There was a significant increase in DNA damage in cells treated with
super physiological concentration of copper (II) sulfate (0.63, 95% CI: 0.17, 1.09) (Figure 5a).
Assessment of DNA damage after oxidative stress induction with menadione showed
that 1.6 µM sodium selenite (−0.92, 95% CI:−1.44,−0.41), both concentrations of potassium
iodide: 0.5 µM (−0.87, 95% CI: −1.49, −0.24), 1 µM (−0.85, 95% CI: −1.42, −0.27) and
the combination of sodium selenite and potassium iodide (−0.95, 95% CI: −1.41, −0.48)
resulted in a significant reduction in DNA damage compared to the menadione alone
control while copper (II) sulfate did not have any significant effect (p > 0.05) (Figure 5b).
While the combination of 0.8 µM sodium selenite and 0.5 µM potassium iodide significantly
reduced DNA damage after menadione treatment, there was no effect with the individual
supplementation of 0.8 µM sodium selenite (p > 0.05). In addition, no significant difference
was found between supplementation with 0.5 µM potassium iodide and the combination
of 0.8 µM sodium selenite and 0.5 µM potassium iodide (p > 0.05) (Figure 5b). Similar
results were seen in DNA damage assessment of placenta explants treated with antimycin
(Figure 5c).
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Figure 5. Effect of selenium, iodine, and copper supplementation on DNA damage in first trimester
human placental explants. Placenta explants from 7 to 12 weeks of gestation (n = 12) were cultured
for 48 h for syncytial regeneration followed by supplementation with sodium selenite (0.8 or 1.6 µM),
potassium iodide (0.5 or 1 µM), combination of odium s lenite and potassium iodide (0.8 µM
sodium selenite and 0.5 µM potassium iodide), or copper (II) sulfate (20 or 40 µM) for 72 h with
supplementation replenished every 24 h. (a) Placental explants were harvested following 72 h of
supplementation and DNA damage assessed by immunolabelling for 8-hydroxy-2′-deoxyguanosine.
After 72 h of supplementation, placental explants were treated with (b) 120 µM menadione or (c)
480 µM ntimycin for 24 h to induce oxidative stress and then assessed for DNA damage. Eight
randomly selected regions per explant were used for quantification and statistical analyses. Data
presented as a fold change (FC) relative to control ± standard error. Statistical significance was
assessed using Generalised Estimating Equations (GEE) with independence correlation structure
with log 2-transformed positive stain per area to estimate fold change compared to controls followed
by pre-specified post-hoc Bonferroni adjusted comparisons. * Indicates statistically different (p < 0.05)
from control.
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4. Discussion
Selenium supplementation increased proliferation and reduced DNA damage and
apoptosis in the absence or presence of oxidative stress. This can be explained by the effect
of selenium on the cell cycle and the antioxidant system [31,32]. Selenium stimulates the
transition from Gap 2 to the mitosis phase in the cell cycle and this increases cell division
or proliferation [32]. The cell cycle is precisely monitored and damaged DNA molecules
can be detected at several checkpoints [33]. Although checkpoints in different cell cycle
phases may work differently, the ultimate outcome is if the DNA molecule is not repaired
the cell containing damaged DNA cannot proliferate and undergoes apoptosis [33]. GPx 4
and TRx are seleno-antioxidant enzymes that can protect cells against oxidative damage
such as DNA damage, therefore reducing apoptosis [34–36]. Supraphysiological levels
of selenium increased proliferation and decreased apoptosis in first trimester placental
tissues [28]. Notably, when placenta explants were treated with menadione or antimycin
the lower concentration of sodium selenite could not reduce DNA damage or apoptosis.
This suggests that under conditions of oxidative stress, cells may require a higher concen-
tration of selenium, that is, supraphysiological levels of selenium, for protection against
oxidative damage.
This study showed that potassium iodide could protect from oxidative damage to
DNA molecules and reduced apoptosis. This is consistent with previous findings show-
ing the protective effect of potassium iodide against oxidative stress in a placenta cell
line [28,37]. Systemically, iodine is a radical scavenger as seen by its ability to metabolise
H2O2 in thyroid hormone production [38]. The exact mechanisms by which iodine interacts
with the antioxidant system in combating oxidative stress has not been clearly defined
but studies have shown that iodine has antioxidant properties such as increasing total
antioxidant status of human serum [39]. Iodine sufficient pregnant women (>150 µg/L
urinary iodine concentration) had higher activity of the enzyme SOD compared to iodine
deficient women [24]. Interestingly, the combination of sodium selenite and potassium
iodide resulted in a greater reduction in DNA damage in antimycin treated cells, compared
to either micronutrient alone. This suggests that combining iodine and selenium may
provide a stronger protection to the placenta against oxidative stress. Iodide and selenium
can form selenenyl iodide that is a substrate for placental TRx and may increase antioxidant
activity of TRx [40], thereby reducing DNA damage and apoptosis.
In a prospective cohort study of 1065 pregnant Australian women, a high level of
maternal plasma copper was associated with higher plasma C-reactive protein (CRP)
concentrations [3]. CRP is an inflammatory biomarker that increases in oxidative stress [41]
and its higher levels are associated with a greater incidence of pregnancy complications
such as preterm birth [42] and preeclampsia [43]. The results of this study showed that
a high concentration of copper increased DNA damage and apoptosis. Excess intake
of copper may increase production of reactive oxygen species and diminish antioxidant
defence systems [44], resulting in DNA damage and apoptosis. Interestingly, in menadione
or antimycin induced oxidative stress the toxic effect of excess copper was not apparent.
To remove reactive molecules and protect the cells against oxidative stress, the antioxidant
system is overexpressed and the activity of enzymes such as SOD1 increases [45]. Therefore,
these enzymes may require higher levels of cofactors including copper. This avoids copper
being accumulated and causing toxic effects.
We could only examine the effect of three essential micronutrients on oxidative stress
in first trimester human placenta. Continued research on a group of micronutrients in pla-
centa samples from other trimesters can address the potential differences across gestation.
Using laser ablation inductively coupled plasma-mass spectrometry in the assessment of
micronutrients uptake is novel and to the best of our knowledge, this is the first study
that has directly mapped selenium and copper content and distribution in cultured pla-
cental explants. However, this method cannot confirm iodine uptake. Further research,
including coupling this method with immunolabeling of different placental cells as well
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as quantifying micronutrients content within the placental explants, may provide a better
understanding of the effect of micronutrients on the placenta.
5. Conclusions
In conclusion, selenium and iodine may protect the first trimester human placenta
against oxidative stress in vitro. An excess intake of copper is related to oxidative damage
to DNA and apoptosis. An optimal level of micronutrients may help to ensure healthy
placental development.
Supplementary Materials: The following are available online at https://www.mdpi.com/2072-664
3/13/3/800/s1, Figure S1: Selenium uptake in first trimester human placental explants, Figure S2:
Copper uptake in first trimester human placental explants, Figure S3: Apoptosis and DNA damage
induction by menadione in first trimester human placental explants.
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